EUVIMEDEUVIMED entdecken
Crossref

Suppression and recovery dynamics of infant parathyroid function; clinical outcomes following maternal primary hyperparathyroidism

Barno Badridinova, Dilrabo Nazarova, Dilafruz Turaeva, Mashkhura Safarova, Dildora Matrasulova, Dilobar Sevinchova, Nigora Khodjayeva, Ekaterina Anvarova, Azizjon Khaydarov, Makhliyo Abdusalomova

Journal of Parathyroid Disease · 19.04.2026 · 14 (1) · e13320

DOI: 10.34172/jpd.2026.13320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parathyroid Disease, online erschienen am 19.04.2026. Verfasst von Barno Badridinova und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maternal primary hyperparathyroidism (PHPT), though rare during pregnancy, poses significant and disproportionate risks to the fetus and newborn due to transplacental passage of maternal calcium and parathyroid hormone (PTH). This condition disrupts the fetal mineral regulatory milieu, establishing a critical pathophysiological sequence. Sustained maternal hypercalcemia directly suppresses the development and function of the fetal parathyroid glands in utero, inducing a state of functional dependence on the maternal hypercalcemic environment for calcium homeostasis. Consequently, at delivery, the abrupt termination of both the maternal hypercalcemic drive and placental calcium transfer precipitates a high-risk period for the neonate. The infant, born with profoundly suppressed parathyroid reserve, faces a substantial challenge in mounting an adequate PTH secretory response to the sudden drop in calcium supply. This pathophysiological lag universally triggers neonatal hypocalcemia, the severity and duration of which are intrinsically linked to the depth and chronicity of in utero parathyroid suppression, as well as the individual neonate’s capacity for parathyroid functional recovery. Clinical manifestations can range from asymptomatic biochemical hypocalcemia to severe, life-threatening complications including seizures, tetany, apnea, and cardiomyopathy. Understanding this mechanistic pathway, from maternal hypercalcemia to fetal gland suppression and the predictable postnatal hypocalcemic crisis is paramount. It underscores the necessity for vigilant prenatal diagnosis of maternal PHPT, meticulous intrapartum planning, and intensive, protocol-driven neonatal monitoring and calcium/active vitamin D replacement strategies to prevent significant neonatal morbidity. Early recognition of this iatrogenic dependence is crucial for optimizing outcomes in affected offspring.

Zitieren

APA

Badridinova, B., Nazarova, D., Turaeva, D., Safarova, M., Matrasulova, D., Sevinchova, D., Khodjayeva, N., Anvarova, E., Khaydarov, A., & Abdusalomova, M. (2026). Suppression and recovery dynamics of infant parathyroid function; clinical outcomes following maternal primary hyperparathyroidism. Journal of Parathyroid Disease, 14(1), e13320. https://doi.org/10.34172/jpd.2026.13320

Vancouver

Badridinova B, Nazarova D, Turaeva D, Safarova M, Matrasulova D, Sevinchova D, et al. Suppression and recovery dynamics of infant parathyroid function; clinical outcomes following maternal primary hyperparathyroidism. Journal of Parathyroid Disease. 2026;14(1):e13320. doi:10.34172/jpd.2026.13320

BibTeX
@article{Badridinova2026,
  author = {Badridinova, Barno and Nazarova, Dilrabo and Turaeva, Dilafruz and Safarova, Mashkhura and Matrasulova, Dildora and Sevinchova, Dilobar and Khodjayeva, Nigora and Anvarova, Ekaterina and Khaydarov, Azizjon and Abdusalomova, Makhliyo},
  title = {Suppression and recovery dynamics of infant parathyroid function; clinical outcomes following maternal primary hyperparathyroidism},
  journal = {Journal of Parathyroid Disease},
  year = {2026},
  volume = {14},
  number = {1},
  pages = {e13320},
  doi = {10.34172/jpd.2026.13320}
}
Kostenlos starten →